whitepaper

Download whitepaper

Multi-criteria decision analysis

Assessing pharmaceuticals for small and rare diseases is seldom straightforward as the standard assessment method is often criticized for being unfit. In this whitepaper we highlight one possible option for assessing pharmaceuticals for small and rare diseases using multi-criteria decision analysis to support the decision-making where multiple criteria, in addition to cost and efficacy, can be arranged and evaluated.